Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jan 30, 2006 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 100 | $48.12 | 15,488 |
Jan 30, 2006 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 750 | $48.10 | 15,588 |
Oct 29, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 6,050 | $107.50 | 15,897 |
Oct 26, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 617 | $105.00 | 15,897 |
Oct 10, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 5,000 | $102.50 | 15,897 |
Oct 09, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 1,086 | $100.00 | 15,897 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 174 | $63.29 | 15,897 |
Feb 22, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,327 | -- | 15,897 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $63.18 | 16,071 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $63.09 | 16,271 |
Jan 30, 2006 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,334 | $21.18 | 16,338 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $63.01 | 16,471 |
Oct 26, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 617 | $48.51 | 16,514 |
Jan 30, 2006 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,334 | -- | 16,666 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 100 | $63.00 | 16,671 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $62.99 | 16,771 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 400 | $62.95 | 16,971 |
Oct 09, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,086 | $20.64 | 16,983 |
Feb 14, 2008 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,459 | $51.38 | 17,356 |
Feb 19, 2014 |
Executive VP & CFO
|
Executive VP & CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,359 | -- | 17,359 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 100 | $62.93 | 17,371 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 100 | $62.92 | 17,471 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $62.88 | 17,571 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $62.85 | 17,771 |
Mar 08, 2007 |
Sr. VP & CFO
|
Sr. VP & CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 300 | $62.80 | 17,971 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.